Rchr
J-GLOBAL ID:201401086045181561   Update date: Sep. 25, 2024

Yuji Kashiwakura

カシワクラ ユウジ | Yuji Kashiwakura
Affiliation and department:
Homepage URL  (1): http://kaken.nii.ac.jp/d/r/40382890.ja.html
Research field  (2): Pathobiochemistry ,  Immunology
Research theme for competitive and other funds  (3):
  • 2021 - 2024 血友病Aブタ血漿を用いたヒト凝固因子測定法の開発
  • 2014 - 2017 Analysis of CD2-mediated gene regulatory mechanisms about function and survival in regulatory T cells
  • 2012 - 2015 Regulatory roles of HIF-1a and glycolysis in autoimmunity
Papers (39):
  • Takafumi Hiramoto, Hiroshi Inaba, Nemekhbayar Baatartsogt, Yuji Kashiwakura, Morisada Hayakawa, Nobuhiko Kamoshita, Hiroshi Nishimasu, Osamu Nureki, Ei Kinai, Tsukasa Ohmori. Genome editing of patient-derived iPSCs identifies a deep intronic variant causing aberrant splicing in hemophilia A. Blood advances. 2023. 7. 22. 7017-7027
  • Yuji Kashiwakura, Kazuhiro Endo, Atsushi Ugajin, Tomohiro Kikuchi, Shuji Hishikawa, Hitoyasu Nakamura, Yuko Katakai, Nemekhbayar Baatartsogt, Takafumi Hiramoto, Morisada Hayakawa, et al. Efficient Gene Transduction in Pigs and Macaques with the Engineered AAV Vector AAV.GT5 for Hemophilia B Gene Therapy. Molecular Therapy - Methods & Clinical Development. 2023. 30. 502-514
  • Takafumi Hiramoto, Yuji Kashiwakura, Morisada Hayakawa, Nemekhbayar Baatartsogt, Nobuhiko Kamoshita, Tomoyuki Abe, Hiroshi Inaba, Hiroshi Nishimasu, Hideki Uosaki, Yutaka Hanazono, et al. PAM-flexible Cas9-mediated base editing of a hemophilia B mutation in induced pluripotent stem cells. Communications Medicine. 2023. 3. 1
  • Nemekhbayar Baatartsogt, Yuji Kashiwakura, Takafumi Hiramoto, Morisada Hayakawa, Nobuhiko Kamoshita, Tsukasa Ohmori. Successful liver transduction by re-administration of different adeno-associated virus vector serotypes in mice. The Journal of Gene Medicine. 2023
  • Yuji Kashiwakura, Nemekhbayar Baatartsogt, Shoji Yamazaki, Azusa Nagao, Kagehiro Amano, Nobuaki Suzuki, Tadashi Matsushita, Akihiro Sawada, Satoshi Higasa, Naoya Yamasaki, et al. The seroprevalence of neutralizing antibodies against the adeno-associated virus capsids in Japanese hemophiliacs. Molecular therapy. Methods & clinical development. 2022. 27. 404-414
more...
MISC (22):
more...
Professional career (1):
  • 博士(医学) (自治医科大学大学院)
Work history (4):
  • 2021/05 - 現在 Jichi Medical University
  • 2020/01 - 2021/04 Jichi Medical University School of Medicine
  • 2011/04 - 2019/12 Dokkyo Medical University School of Medicine
  • 2010/04 - 2011/03 Jichi Medical University
Awards (5):
  • 2023/09 - 日本遺伝子細胞治療学会 第29回 日本遺伝子細胞治療学会学術集会 JGM賞
  • 2019/06 - 日本血栓止血学会 第41回日本血栓止血学会学術集会 一般演題優秀賞
  • 2014/05 - Japanese Society on Thrombosis and Haemostasis The XIX Congress of the JSTH, Young Researcher's Award Development of cell-based therapy for hemophilic arthropathy
  • 2012 - International Society on Thrombosis and Haemeostasis Pier M. Mannucci Young Investigator Prize 2012
  • 2011/07 - International Society on Thrombosis and Haemostasis The XXIII Congress of the ISTH Award - JSTH Asian-Pacific Scholarship
Association Membership(s) (5):
Japan Society of Gene and Cell Therapy ,  THE JAPANESE SOCIETY FOR IMMUNOLOGY ,  International Society on Thrombosis and Haemostasis ,  THE JAPANESE SOCIETY OF HEMATOLOGY ,  THE JAPANESE SOCIETY ON THROMBOSIS AND HEMOSTASIS
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page